Skip to content
Header Image
Market Spectator

Market Spectator

  • Home
  • Terms of Service
  • Privacy Policy
  • Disclaimer
  • Contact Us
  • Home
  • 2024
  • February
  • 5
  • Novartis to acquire cancer-focused MorphoSys for $2.9 billion
  • The logo of Swiss drugmaker Novartis AG is seen at

The logo of Swiss drugmaker Novartis AG is seen at

The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann/File Photo

Post navigation

Novartis to acquire cancer-focused MorphoSys for $2.9 billion

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

  • Nvidia’s supply snags limit deliveries even as demand booms
  • Exclusive-Amazon likely to face investigation under EU tech rules next year, sources say
  • Automakers urge Trump to preserve EV tax credits, boost self-driving cars
  • Crypto industry jockeys for seats at Trump’s promised council
  • Elf Beauty stock slides after Muddy Waters says it has shorted its shares

Recent Comments

No comments to show.

Copyright © 2024 Market Spectator | Ace News by Ascendoor | Powered by WordPress.

We use cookies to ensure that we give you the best experience on our website.Ok